Maxime Dely: The Human Eye – Irreplaceable Guardian of Blood Transfusion
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, shared a post on LinkedIn:
“The human eye: Irreplaceable guardian of blood transfusion
In an era where artificial intelligence is revolutionizing medicine and robotization is transforming our laboratories, one field remains steadfast: visual control in blood transfusion.
Colorimetry: diagnosis at a glance
Every blood product tells a story through its color.
Turbid plasma? It’s lipemic.. A greenish tint? Trace of oral contraceptives. A pinkish coloration? Sign of hemolysis.
These instant observations guide our daily decisions.
Red blood cell concentrates reveal their quality through the coloration of the supernatant after storage. Simple, yet no machine can replace this human vigilance.
Swirling: when platelets dance
The most fascinating control? Platelet “swirling” – that whirling dance observed with the naked eye that testifies to their viability. An absent movement immediately alerts to degradation.
The leuko-platelet layer, with its creamy hue, also provides information on residual platelet quantity.
Expertise that cannot be digitized
These visual controls are essential safety barriers. Each professional develops a particular acuity, an abilty to perceivesubtle nuances.
This expertise is transmitted, refined – but cannot be robotized.
Blood transfusion illustrates the perfect balance between technology and human expertise. Automated systems optimize, IT systems trace, but it’s the trained eye that validates final quality.
Let’s value this human dimension
Behind every transfused bag lies the attentive gaze of a professional. In blood transfusion, the human eye remains our most precious safety instrument.”

Get the latest from Hemostasis Today.
-
Apr 3, 2026, 17:59A Free Hemoglobin Screening Camp for Kaikadi Vasti and Eramushti Community Women – Hope Foundation Sironcha
-
Apr 3, 2026, 17:53Carlos Henrique Del Carlo: HFpEF and Iron Deficiency – Why Treating the Mitochondrial Engine Matters More Than We Thought?
-
Apr 3, 2026, 17:46Michelle Leona Cecil: A Call to Protect Patient Care and The Nation’s Blood Supply for Blood Disorders Community
-
Apr 3, 2026, 17:38Shahab Sheikhalishahi: A Rare Case of Portal Vein Thrombosis After Echis Carinatus Envenomation
-
Apr 3, 2026, 17:33Kimberly Ha: Epia Neuro Aims to Restore Movement in Stroke Survivors
-
Apr 3, 2026, 17:28Ryan Perry: Heart and Stroke Announces 2026 Grants-in-Aid Indigenous Research Stream Funding Opportunity
-
Apr 3, 2026, 17:21Maxime Dely: A Meaningful Journey of 14 years in Blood Transfusion
-
Apr 3, 2026, 17:19Arun V J: Don’t Miss TRANSCON 2026 – A Direct Pathway Into India’s Clinical and Institutional Network
-
Apr 3, 2026, 17:17Louise St. Germain Bannon: Preparating for ISTH 2026 and Highlighting Best Aspects of Congress